Doctiplus - We are allways here!
Mental Health & Depression
Weekly Report
- 78 new clinical trials registered across 10 countries.
- 3,247 trials actively recruiting patients worldwide.
- Notable trial: Concomitant Fibromyalgia and Psychiatric Disorders (56716 patients).
- 537 new research papers published.
- Drug safety: Most reported effect across tracked medications (sertraline, fluoxetine, escitalopram, venlafaxine, duloxetine) was Off Label Use.
- 8 active drug recall alert(s) — see details below.
The week in numbers
Trials by country
Trials by phase
New clinical trials registered this week for Mental Health & Depression. Each trial links to its full record on ClinicalTrials.gov where you can find eligibility criteria, locations, and contact information.
This week's new registrations
78 trials registered for Mental Health & Depression. Each links to its full record on ClinicalTrials.gov.
| # | Trial ↓ | Phase ↕ | Status ↕ | Enrollment ↕ | Country ↕ |
|---|---|---|---|---|---|
| 01 | Effectiveness of Internet-based Unified Protocol (iUP) for Emotional Problems: A Randomized Controlled Trial Mental Health & Depression · New Life Psychiatric Rehabilitation Association (NCT07908628) | Other | Not Yet Recruiting | 78 | Hong Kong |
| 02 | Media Use, Anxiety, Sedation, and Recovery in Children Having Upper GI Endoscopy Mental Health & Depression · Bahçeşehir University (NCT07916168) | Other | Not Yet Recruiting | 60 | N/A |
| 03 | Examining the Effectiveness of a Brief Therapeutic Intervention for Reducing Self-Harm Among Adolescents Mental Health & Depression · University of Haifa (NCT07913425) | Other | Not Yet Recruiting | 40 | Israel |
| 04 | Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences Mental Health & Depression · Institute of Mental Health, Singapore (NCT07921446) | Other | Not Yet Recruiting | 140 | N/A |
| 05 | EFFECTS OF REFORMER PILATES TRAINING Mental Health & Depression · Aksaray University (NCT07911917) | Other | Completed | 24 | Turkey (Türkiye) |
| 06 | Psychological and Physiological Effects of Three-Minute Breathing Space Meditation in UPM Postgraduate Students Mental Health & Depression · ZIRUI LIU (NCT07911020) | Other | Not Yet Recruiting | 120 | Malaysia |
| 07 | Curcumin Nano Patch and Autonomic Function in Shift-Working Healthcare Professionals Mental Health & Depression · Taipei Medical University Shuang Ho Hospital (NCT07910279) | Other | Completed | 51 | Taiwan |
| 08 | Antipsychotic Safety and Adherence in Patients With Psychiatric Disorders-An Egyptian Institution-Based Cross-Sectional Study. Mental Health & Depression · Egyptian Chinese University (NCT07914192) | Other | Not Yet Recruiting | 250 | N/A |
| 09 | Advancing Cardiovascular Health Among Adolescents With Intellectual Disabilities: Co-Development of Technology Interventions to Enhance Physical Activity Mental Health & Depression · Michigan State University (NCT07919171) | Other | Not Yet Recruiting | 77 | N/A |
| 10 | Functional Impact of Psychological Symptoms in Patients With Superior Semicircular Canal Dehiscence Syndrome (SSCD): a National Cross-sectional Study Mental Health & Depression · University Hospital, Toulouse (NCT07922447) | Other | Not Yet Recruiting | 300 | N/A |
| 11 | Pre-Examination Reflexology for Anxiety and Pain During Pelvic Examination Mental Health & Depression · Goni Sintov (NCT07910136) | Other | Not Yet Recruiting | 120 | Israel |
| 12 | Effect of the 4-7-8 Breathing Technique Before Central Venous Catheter Insertion Mental Health & Depression · Mersin University (NCT07917585) | Other | Completed | 80 | Turkey (Türkiye) |
| 13 | Video- and Game-Based Interventions During Pediatric Peripheral Venous Catheterization Mental Health & Depression · Selcuk University (NCT07914374) | Other | Completed | 120 | Turkey (Türkiye) |
| 14 | Effects of Virtual Reality Environments on Walking in Adults With and Without Knee Osteoarthritis Mental Health & Depression · University of Primorska (NCT07920120) | Other | Recruiting | 60 | Lithuania |
| 15 | HERDA: Pharmacist-Led Culturally Adapted Intervention for Depression Medication Adherence Mental Health & Depression · Gadjah Mada University (NCT07915427) | Other | Active Not Recruiting | 72 | Indonesia |
| 16 | Virtual Reality Assisted Trauma Focused CBT Mental Health & Depression · Queen's University, Belfast (NCT07914634) | Other | Recruiting | 40 | United Kingdom |
| 17 | Video-Based Preoperative Education for Anxiety in Patients Undergoing Anal Fistula Surgery Mental Health & Depression · Afyonkarahisar Health Sciences University (NCT07914530) | Other | Completed | 72 | Turkey (Türkiye) |
| 18 | Be Body Brave: Digital Written Exposure Therapy for Eating Disorders Mental Health & Depression · University of Louisville (NCT07914712) | Other | Not Yet Recruiting | 900 | N/A |
| 19 | §SMOKE Nicotine and Tobacco Youth Cohort Mental Health & Depression · University of Southern Denmark (NCT07910331) | Other | Recruiting | 10,000 | Denmark |
| 20 | High-Tech, High-Touch Mental Health & Depression · Touro University, California (NCT07916818) | Other | Completed | 43 | United States |
| 21 | Evaluation of the Effects of Virtual Reality Applications on Salivary Cortisol Levels and Vital Signs in Adults With Dental Anxiety During Restorative Dental Treatments Mental Health & Depression · Dokuz Eylul University (NCT07911475) | Other | Completed | 250 | Turkey (Türkiye) |
| 22 | Inspiratory Muscle Training and Diaphragmatic Breathing in GAD Mental Health & Depression · Saglik Bilimleri Universitesi (NCT07913503) | Other | Recruiting | 51 | Turkey (Türkiye) |
| 23 | Virtual Reality to Reduce Anxiety During Thoracic Epidural Placement. Mental Health & Depression · Universitaire Ziekenhuizen KU Leuven (NCT07911436) | Other | Not Yet Recruiting | 78 | N/A |
| 24 | FLOW: Influence of the Menstrual Cycle on Alcohol Use in Women Mental Health & Depression · Hospices Civils de Lyon (NCT07910643) | Other | Not Yet Recruiting | 2,000 | France |
| 25 | Parent-Based Intervention for Childhood Avoidant/Restrictive Food Intake Disorder (ARFID) Mental Health & Depression · Yale University (NCT07916974) | Other | Not Yet Recruiting | 110 | United States |
| 26 | Effects of an Anxiety-Reduction Program in Adults Undergoing Awake Hand Surgery Mental Health & Depression · Muhammet Okkan (NCT07918482) | Other | Completed | 120 | Turkey (Türkiye) |
| 27 | Effect of Clinical Simulation on Suicide Care Competency and Suicide Stigma Levels of Psychiatric Nursing Students Mental Health & Depression · Medipol University (NCT07913659) | Other | Completed | 110 | Turkey (Türkiye) |
| 28 | Psilocybin FCR Early-Stage Breast Cancer Mental Health & Depression · NYU Langone Health (NCT07909408) | Phase 2 | Not Yet Recruiting | 100 | United States |
| 29 | Effect of a Novel Episiotomy Repair Simulator on Midwifery Students' Self-Efficacy and Anxiety Mental Health & Depression · Sakarya University (NCT07923331) | Other | Not Yet Recruiting | 106 | N/A |
| 30 | Affective Cognitive Training in Mood Disorders and High-risk Relatives Mental Health & Depression · Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital (NCT07920302) | Other | Recruiting | 100 | Denmark |
| 31 | Temporal Interference Transcranial Alternating Current Stimulation Targeting the BNST or Amygdala for Generalized Anxiety Disorder Mental Health & Depression · Central South University (NCT07909200) | Other | Not Yet Recruiting | 75 | China |
| 32 | Comprehensive Assessment of Rehabilitation Experience Using the SAFE Scale Mental Health & Depression · Fondazione Don Carlo Gnocchi ETS (NCT07912372) | Other | Recruiting | 68 | Italy |
| 33 | Concomitant Fibromyalgia and Psychiatric Disorders Mental Health & Depression · Sergio Gabriel Susmallian (NCT07920913) | Other | Completed | 56,716 | Israel |
| 34 | Time Course of Clozapine-associated Agranulocytosis Over 19 Years Mental Health & Depression · Sheba Medical Center (NCT07913529) | Other | Completed | 2,020 | Israel |
| 35 | The Effects of Extreme Prematurity on Parenting Mental Health & Depression · Centre Hospitalier Universitaire de Besancon (NCT07918365) | Other | Not Yet Recruiting | 30 | N/A |
| 36 | Financial Tools Access and Navigation (FinTAN) Mental Health & Depression · Yale University (NCT07920874) | Other | Not Yet Recruiting | 60 | United States |
| 37 | Application of Meaning-Based Psychotherapy to a Sample of Patients With Chronic Pain Mental Health & Depression · Hospital Clinico Universitario San Cecilio (NCT07915440) | Other | Recruiting | 118 | Spain |
| 38 | Healing Through Play Mental Health & Depression · Al-Zaytoonah University of Jordan (NCT07909798) | Other | Completed | 60 | Jordan |
| 39 | Effects of Tabletop Role-Playing Games on Nursing Students Mental Health & Depression · Kocaeli University (NCT07914699) | Other | Completed | 230 | Turkey (Türkiye) |
| 40 | Group Mental Health Intervention With Syrian Refugee Women in Turkey Mental Health & Depression · Brigham Young University (NCT07914127) | Other | Completed | 148 | Turkey (Türkiye) |
| 41 | Pain Perception With Cordless Electronic Local Anesthetic Delivery System Mental Health & Depression · National Research Centre, Egypt (NCT07915531) | Other | Recruiting | 22 | Egypt |
| 42 | Effects of Qigong Exercise on Anxiety and Depression in Patients Receiving Inpatient Treatment for Substance Use Disorder Mental Health & Depression · Uskudar University (NCT07909447) | Other | Completed | 70 | Turkey (Türkiye) |
| 43 | Aroma Inhalation and Exam Stress: Role of Emotional Intelligence and Stress Biomarkers Mental Health & Depression · Gulbahar Boyuk Ozcan (NCT07922304) | Other | Completed | 94 | Turkey (Türkiye) |
| 44 | Neurostructural and Biochemical Signatures of Tobacco Smoking in Mood Disorders Mental Health & Depression · Assiut University (NCT07910318) | Other | Not Yet Recruiting | 240 | N/A |
| 45 | Effects of High-Intensity Interval Training and Moderate-Intensity Continuous Training on Psychological Distress and Self-Regulation in Insufficiently Active Male University Students Mental Health & Depression · Burcu Sıla SEZER (NCT07917169) | Other | Completed | 36 | Turkey (Türkiye) |
| 46 | Effects of Transcranial Direct Current Stimulation and Manual Therapy on Musculoskeletal Pain in Adolescent Dancers Mental Health & Depression · Gwangju Health University (NCT07917702) | Other | Not Yet Recruiting | 24 | South Korea |
| 47 | Impacto 2.0: Mobile Smoking Cessation Across Texas Mental Health & Depression · Michael J. Zvolensky, Ph.D. (NCT07915973) | Other | Not Yet Recruiting | 100 | United States |
| 48 | Adapting the "Do More, Feel Better" Intervention for Older People Living With HIV Mental Health & Depression · University of Washington (NCT07915934) | Other | Not Yet Recruiting | 48 | United States |
| 49 | The Effectiveness of Comic-based Learning Materials on Nursing Students' Knowledge, Attitudes, and Confidence in Dementia Care Mental Health & Depression · Taipei Medical University (NCT07922109) | Other | Not Yet Recruiting | 84 | N/A |
| 50 | Long-term Impacts of Psychosocial Stimulation and Iron Supplementation Mental Health & Depression · International Centre for Diarrhoeal Disease Research, Bangladesh (NCT07919327) | Other | Enrolling By Invitation | 379 | Bangladesh |
Adverse event reports
Adverse drug event reports compiled from the FDA's FAERS database for medications commonly prescribed for Mental Health & Depression. These reports reflect what patients and healthcare providers have reported — they do not confirm a drug caused the effect.
Reports by drug
| Drug | Top effect | Count |
|---|---|---|
| sertraline | Nausea | 961 |
| fluoxetine | Off Label Use | 508 |
| escitalopram | Fatigue | 726 |
| venlafaxine | Off Label Use | 738 |
| duloxetine | Nausea | 672 |
Recalls & safety notices
FDA drug recall notices for medications related to Mental Health & Depression. If your medication is listed, contact your pharmacist or visit fda.gov/safety/recalls for guidance. No recall listed does not guarantee safety — always consult your healthcare provider.
DULOXETINE HYDROCHLORIDE
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above safety assessment limit
DULOXETINE HYDROCHLORIDE
CGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
DULOXETINE HYDROCHLORIDE
CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit
DULOXETINE HYDROCHLORIDE
CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.
DULOXETINE HYDROCHLORIDE
CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.
DULOXETINE HYDROCHLORIDE
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
DULOXETINE
CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability intervals.
DULOXETINE HYDROCHLORIDE
CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit
Published research
Recently published peer-reviewed studies related to Mental Health & Depression, sourced from PubMed and Semantic Scholar. Click any title to read the full paper, or expand the abstract for a quick summary.
| # | Study | Journal | Date | Source |
|---|---|---|---|---|
| 01 |
Cognitive disengagement syndrome and alexisomia: examining the moderating role of anxiety-depression symptoms, stress, and insomnia symptoms among a sample of Lebanese adults.
View abstractBACKGROUND: The interplay between body and mind is at the heart of processing bodily states. Alexisomia refers to the lack of somatic awareness, whereas cognitive disengagement syndrome (CDS) is a cluster of symptoms that reflect mental sluggishness, daydreaming, and hypoactivity. Given that interoceptive accuracy relies on attention to internal signals, the hypoactive characteristics of CDS may attenuate interoceptive processing; therefore, individuals with higher CDS traits might show diminished awareness of bodily states. This study investigates the association between CDS and alexisomia, as well as the moderating effect of anxiety-depression symptoms, stress, and insomnia symptoms. METHOD: A cross-sectional study was conducted among 877 Lebanese adults aged 18-70 years, recruited through snowball sampling. Data were collected using a Google Forms questionnaire that included the Adult Concentration Inventory, the Shitsu Taikan Sho Scale, the Stress Numerical Rating Scale, the Patient Health Questionnaire-4, and the Insomnia Severity Index. Of the participants, 64.3% were female, and 35.7% were male. RESULTS: The interaction models were adjusted over the following variables: marital status, education, and living situation. The CDS × anxiety-depression (B = -0.04, p = .011) and CDS × insomnia (B = -0.03, p = .002) interactions were significantly associated with alexisomia, whereas the CDS × stress interaction (B = -0.03, p = .076) was not statistically significant after applying heteroscedasticity-consistent standard errors. At low (-1 SD), mean, and high (+1 SD) levels of anxiety - depression and insomnia, higher CDS levels were significantly associated with higher levels of alexisomia. Additionally, higher levels of anxiety-depression and insomnia symptoms attenuated the positive association between CDS traits and alexisomia. CONCLUSION: Findings highlight an interplay between symptoms of cognitive disengagement and reduced somatic awareness, while emphasizing the importance of accounting for psychological distress and sleep disturbance when studying this relationship. Understanding these interactions provides a foundation for future longitudinal research to further clarify the nature and temporal relationships among these constructs. |
Psychology, health & medicine | 2026 Nov 8 | PubMed |
| 02 |
Switching to Tildrakizumab 200 mg after Anti-IL-17 Failure in Moderate-to-Severe Psoriasis: A 52-Week Prospective Real-World Study.
View abstractINTRODUCTION: Switching between biologic therapies is a common strategy in the management of moderate-to-severe psoriasis after treatment failure. However, prospective real-world data on switching from interleukin (IL)-17 inhibitors to IL-23 inhibitors remain limited. This study aimed to evaluate the clinical effectiveness, patient-reported outcomes, and dose selection associated with switching to tildrakizumab in patients with moderate-to-severe plaque psoriasis after failure of IL-17 inhibitor therapies. METHODS: In this prospective real-world study, 30 patients who failed a single IL-17 inhibitor were switched to tildrakizumab and followed for 52 weeks. Clinical outcomes (Psoriasis Area and Severity Index [PASI] and Physician Global Assessment [PGA]), response rates (75%, 90%, and 100% improvement in PASI score [PASI75, PASI90, and PASI100]), and patient-reported outcomes (Dermatology Life Quality Index [DLQI], World Health Organization-Five Well-Being Index [WHO-5], and nine-item Treatment Satisfaction Questionnaire for Medication [TSQM-9]) were assessed at baseline and weeks 4, 16, and 52. RESULTS: Rapid and sustained clinical improvement was observed, with mean PASI scores decreasing from 12.2 at baseline to 1.1 at week 52. At week 52, 88.9% of patients achieved PASI75, 66.7% PASI90, and 50% PASI100, while 94.4% reached PASI scores ≤ 3. Significant improvements were also observed in DLQI and WHO-5 scores, alongside high treatment satisfaction. Although 46.7% of patients initially received 100 mg, all were subsequently escalated to 200 mg, with no patients maintaining the lower dose throughout follow-up. CONCLUSIONS: Switching to tildrakizumab after anti-IL-17 failure resulted in significant clinical and patient-reported benefits over 52 weeks. Dose escalation from 100 to 200 mg was frequently observed during follow-up; however, the absence of a comparator group maintained on 100 mg precludes conclusions regarding the comparative effectiveness of the two dosing regimens. |
Dermatology and therapy | 2026 Nov 8 | PubMed |
| 03 |
Peripheral Brain-Derived Neurotrophic Factor Changes and Clinical Response to Electroconvulsive Therapy and Repetitive Transcranial Magnetic Stimulation in Major Depressive Disorder: A Systematic Review.
View abstractMajor depressive disorder (MDD) is a leading contributor to the global burden of disease, and a substantial proportion of patients experience inadequate responses to conventional treatments. Brain-derived neurotrophic factor (BDNF), a key regulator of neuronal survival and synaptic plasticity, has been investigated as a potential biomarker of antidepressant response. However, its clinical relevance following brain stimulation remains uncertain. This systematic review evaluated changes in peripheral BDNF concentrations and their association with clinical outcomes following electroconvulsive therapy (ECT) and repetitive transcranial magnetic stimulation (rTMS) in adults with MDD. The review followed Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) 2020 guidelines, and searches were conducted in PubMed/MEDLINE (Medical Literature Analysis and Retrieval System Online), PsycINFO, and LILACS (Latin America and the Caribbean Literature on Health Sciences). Study selection and data extraction were independently performed by two reviewers, with disagreements resolved through consensus or consultation with a third reviewer. Eleven studies met the eligibility criteria, including two randomized controlled trials and nine non-randomized investigations. Due to substantial clinical and methodological heterogeneity, a meta-analysis was not performed, and findings were synthesized narratively. Peripheral BDNF responses varied across interventions, biological matrices, and sampling intervals. While many studies reported increased serum or plasma BDNF following ECT, others documented substantial clinical improvement without corresponding biomarker changes. Evidence following rTMS was less consistent, with insufficient data to establish a reliable association between BDNF changes and antidepressant response. Overall, peripheral BDNF changes did not consistently parallel clinical improvement, and current evidence does not support their use as a standalone biomarker of antidepressant response. Further adequately powered studies with standardized biomarker measurements and longitudinal clinical assessments are warranted. |
Cureus | 2026 Nov | PubMed |
| 04 |
Configurations Associated with High Self-Regulatory Fatigue in Patients with Stroke: A Fuzzy-Set Qualitative Comparative Analysis.
View abstractBACKGROUND: Self-regulatory fatigue is common among patients with stroke and may adversely affect rehabilitation. Previous studies have mainly examined individual factors associated with self-regulatory fatigue, but how multiple stressor-related and resource-related conditions combine into distinct configurations of high self-regulatory fatigue remains unclear. PURPOSE: To identify configurations associated with high self-regulatory fatigue among patients with stroke using fuzzy-set qualitative comparative analysis (fsQCA), guided by Conservation of Resources theory. PATIENTS AND METHODS: A total of 288 patients with stroke were recruited from the neurology wards of a tertiary hospital in Zhejiang Province, China. Data were collected using validated instruments assessing self-regulatory fatigue, depressive symptoms, sense of coherence, perceived social support, stroke health literacy, activities of daily living, and neurological impairment. Necessity and sufficiency analyses were conducted using fsQCA to identify conditions and configurations associated with high self-regulatory fatigue. RESULTS: No single condition was necessary for high self-regulatory fatigue. Five configurations were identified, with an overall solution consistency of 0.937 and an overall solution coverage of 0.640. The configurations were categorised into three types: psychological-emotional resource depletion type, functional-social resource depletion type, and multi-resource synergistic depletion type. Robustness analyses supported the stability of the configurational findings. CONCLUSION: High self-regulatory fatigue among patients with stroke is associated with distinct configurations of psychological, functional, social, and health-management resource deficits rather than any single condition. These findings support multidimensional assessment and coordinated multidisciplinary care tailored to patients' resource profiles. |
Journal of multidisciplinary healthcare | 2026 | PubMed |
| 05 |
Pandemic-Driven Mental Health Deterioration and Suicide Risk Among Health Science Students: A Longitudinal Cohort Study Unmasking the Trauma Multiplier Effect.
View abstractBACKGROUND: The COVID-19 pandemic precipitated an unprecedented mental health crisis among healthcare trainees-a population already burdened by academic and occupational stressors. The mediating role of prior trauma exposure in shaping longitudinal suicide risk trajectories remains critically underexplored. OBJECTIVE: To quantify pandemic-attributable deterioration in mental health and identify independent predictors of escalating suicide risk in a prospective health student cohort. METHODS: A prospective longitudinal cohort study was conducted across 11 health science disciplines (n = 1401; 86.3% retention). The Depression Anxiety Stress Scale-21 (DASS-21) and Suicide Behaviors Questionnaire-Revised (SBQ-R) were administered pre-pandemic (January 2020) and during the pandemic (January 2022). McNemar's test, multivariable logistic regression, and Generalized Estimating Equations (GEE) were employed. RESULTS: Anxiety prevalence increased from 48.5% before the pandemic to 64.4% during the pandemic, corresponding to an observed absolute risk difference of 15.9 percentage points and a descriptive Number Needed to Harm (NNH) of approximately 7. High suicide risk rose from 12.1% to 15.4% (paired OR = 1.33, 95% CI: 1.16-1.52). History of violence was the strongest predictor of high suicide risk (adjusted OR [aOR] = 3.30, 95% CI: 1.62-6.73), with a significant Time × Violence interaction in GEE modelling (aOR = 1.53, 95% CI: 1.17-1.99), confirming the pandemic as a "trauma multiplier". The model demonstrated excellent discrimination (AUC = 0.85). CONCLUSION: Pandemic conditions disproportionately escalated suicide risk in health students with prior trauma exposure. Universal trauma screening and targeted mental health interventions must be integrated into health science curricula to mitigate compounding risk during future crises. |
Journal of multidisciplinary healthcare | 2026 | PubMed |
| 06 |
Latent Profile Subtypes of Depressive Symptoms and Associated Factors Among Elderly Patients with Chronic Heart Failure.
View abstractOBJECTIVE: To identify latent subtypes of depressive symptoms and their associated factors among elderly patients with chronic heart failure (CHF), so as to provide reference for developing targeted psychological intervention strategies. METHODS: A cross-sectional survey enrolled 423 hospitalized elderly CHF patients from June 2025 to May 2026. Assessments included SDS, SAS, Family APGAR, MLHFQ and PNI. Different from conventional SDS total-score-based severity grouping, latent profile analysis (LPA) was performed based on item-level responses of the Self-Rating Depression Scale (SDS) to derive depressive symptom profiles. Univariate tests and multinomial logistic regression were used to examine variables associated with profile membership. RESULTS: Three depressive-symptom latent profiles were identified from SDS item-level data, which largely followed a mild-to-moderate-to-severe symptom gradient: mild low-symptom type (50.35%), moderate emotion-predominant type (34.52%), severe somatic-cognitive type (15.13%). NYHA class III (OR=2.444, 95% CI: 1.238-4.823) / IV (OR=4.301, 95% CI: 1.814-10.196), living alone (OR=2.887, 95% CI: 1.630-5.113), and malnutrition (OR=1.775, 95% CI: 1.022-3.082) were independently associated with membership in the moderate emotion-predominant profile. Widowhood/divorce (OR=9.226, 95% CI: 2.695-31.586), polypharmacy (≥6 drugs) (OR=5.856, 95% CI: 1.295-26.472), and severe anxiety (OR=4.911, 95% CI: 1.275-18.921) were exclusive associated factors for the severe somatic-cognitive profile. Advanced cardiac dysfunction, solitary living and family dysfunction elevated odds for both moderate and severe profiles; mild anxiety (OR=0.183, 95% CI: 0.036-0.932) and moderate quality of life (OR=0.069, 95% CI: 0.006-0.758) were associated with lower odds of belonging to the severe-symptom profile. CONCLUSION: Depressive symptoms among elderly CHF patients show obvious heterogeneity and present an overall mild-to-moderate-to-severe symptom gradient. Our findings highlight potential high-risk groups (solitary-living patients, malnourished patients, patients with severe cardiac dysfunction and poor family support). These observational results may inform future development of stratified psychological-intervention approaches, although intervention effectiveness was not evaluated in the present cross-sectional study. |
Journal of multidisciplinary healthcare | 2026 | PubMed |
| 07 |
Cerebral Small Vessel Disease and Its Associations with Cognitive Impairment, Gait Disturbance, and Europsychiatric Symptoms: A Narrative Review.
View abstractCerebral small vessel disease (CSVD) encompasses a heterogeneous group of pathological processes affecting the small arteries, arterioles, capillaries, and venules of the brain. Beyond its well-recognized role in lacunar stroke and intracerebral hemorrhage, CSVD is increasingly understood as a major contributor to cognitive decline, gait impairment, and mood disturbances in older adults. These non-stroke manifestations often coexist and share common pathophysiological substrates, including endothelial dysfunction, blood-brain barrier disruption, chronic hypoperfusion, neuroinflammation, oxidative stress, and disruption of structural and functional brain networks. This narrative review synthesizes current evidence on the epidemiology, neuroimaging markers, and pathophysiological mechanisms of CSVD, with particular attention to its associations with cognitive impairment (predominantly executive dysfunction and slowed processing speed), gait abnormalities (reduced walking speed, increased stride variability, and elevated fall risk), and europsychiatric symptoms (vascular depression, apathy, and anxiety). The interactive relationships among these clinical phenotypes and the amplifying effects of comorbidities such as diabetes are also discussed. Finally, we review existing intervention strategies, particularly blood pressure control, and highlight emerging therapeutic targets and unresolved questions that warrant further investigation. |
International journal of general medicine | 2026 | PubMed |
| 08 |
Music-based interventions for anxiety and depression in adult cancer patients: an umbrella review of the evidence landscape and methodological quality.
View abstractBACKGROUND: Music-based interventions have been increasingly investigated as complementary approaches for managing anxiety and depression among adults with cancer. However, the growing number of systematic reviews has resulted in heterogeneous conclusions, and the methodological robustness and characteristics of the existing evidence synthesis landscape remain uncertain. This umbrella review aimed to critically appraise the evidence landscape and methodological quality of systematic reviews evaluating music-based interventions for anxiety and depression in adults with cancer. METHODS: An appraisal-focused umbrella review was conducted. We systematically searched PubMed, Web of Science, Embase, EBSCO, Scopus, Wiley Online Library, Cochrane Database of Systematic Reviews, ProQuest, China National Knowledge Infrastructure (CNKI), Wanfang Data, and VIP Database from inception to January 6, 2026. Systematic reviews of randomized controlled trials evaluating music-based interventions for anxiety and/or depression in adults with cancer were eligible for inclusion. Two reviewers independently performed study selection, data extraction, and methodological appraisal. Methodological quality was assessed using A Measurement Tool to Assess Systematic Reviews 2 (AMSTAR 2), risk of bias was evaluated using the Risk Of Bias In Systematic Reviews tool (ROBIS), and overlap among primary studies was quantified using the corrected covered area (CCA). Narrative synthesis was conducted without new meta-analysis or quantitative reanalysis. RESULTS: Twenty systematic reviews published between 2015 and 2025 were included. All included systematic reviews incorporated quantitative synthesis, including one network meta-analysis. Among the 19 reviews assessed using AMSTAR 2, 17 (89.47%) were rated as having low or critically low confidence in their findings. ROBIS assessment showed that 12 reviews (60%) had a high risk of bias, whereas 5 (25%) were judged as having a low risk of bias. Overlap among primary studies was slight, with CCA values of 5.04% for anxiety and 3.97% for depression. Although most systematic reviews reported beneficial effects of music-based interventions, interpretation of these findings was limited by methodological concerns, risk of bias, and inconsistent reporting of certainty assessments. CONCLUSION: This umbrella review indicates that music-based interventions may have beneficial effects on anxiety and depression outcomes in adults with cancer; however, confidence in these findings is constrained by limitations in the methodological quality and reporting of existing systematic reviews. Future evidence syntheses should prioritize rigorous methodology, transparent reporting, and improved assessment of evidence certainty to strengthen the evidence base for music-based interventions in cancer care. |
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2026 Nov 7 | PubMed |
| 09 |
Reduced attenuation of neural activation during fear extinction learning in patients with anxiety disorders: a delayed fear extinction fMRI study.
View abstractClarifying the patterns of neural activation during fear extinction in anxiety disorders (ADs) is essential for advancing our understanding of inhibitory learning. However, the underlying mechanisms remain poorly characterized in large, heterogeneous cohorts of patients. Utilizing a delayed fear extinction fMRI paradigm, this study examined neural responses in 280 patients with ADs - comprising panic disorder, agoraphobia, panic disorder with agoraphobia, social anxiety disorder, and multiple specific phobias - compared to 103 healthy controls (HC). The attenuation of neural activation to conditioned fear (CS+) and safety (CS-) stimuli from early versus late extinction was compared between groups. Subjective ratings of US-expectancy, arousal, and valence were also collected. In a whole-brain voxelwise analysis, patients showed significantly reduced attenuation of neural activation across both CS+ and CS- relative to HC from early compared to late phases of extinction learning. This pattern was observed in a broad network, encompassing the insular cortex (IC) and bilateral supplementary motor area (SMA), among other regions. No interaction between group and stimulus type was observed. Region-of-interest analysis of the left anterior insular cortex confirmed that reduced attenuation in this region represents a robust neural signature of altered extinction learning in ADs. Furthermore, patients reported persistently higher fear expectancy and arousal than HC, consistent with sustained alterations in threat-related processing following extinction training. Together, these findings highlight altered extinction-related neural attenuation as a transdiagnostic feature of ADs, offering novel insights into the neural mechanisms underlying fear extinction. |
Translational psychiatry | 2026 Nov 7 | PubMed |
| 10 |
The bridge crisis clinic: an ambulatory crisis stabilization model within the pediatric behavioral health crisis continuum.
View abstractOBJECTIVE: Pediatric behavioral health crises increasingly require care pathways between routine outpatient treatment and emergency or inpatient psychiatric services. This study describes the implementation and preliminary outcomes of the Bridge Crisis Clinic (BCC), an ambulatory crisis-stabilization program within a pediatric health system. METHODS: A retrospective quality-improvement evaluation was conducted using medical-record data from youth receiving BCC services between June 2024 and March 2025. BCC provides short-term psychiatric assessment, medication management, crisis-focused therapy, suicide-risk monitoring, family support, and care coordination for youth ages 6 to 18 years experiencing acute behavioral health deterioration. Program performance was evaluated across access, measurement-based care, clinical stabilization, and transition to ongoing treatment. RESULTS: Among 533 accepted referrals, 461 youth received care through BCC (mean age, 12.9 years). Median time from referral to intake was 14 days, meeting the program benchmark. Measurement-based care was incorporated through standardized depression, anxiety, and suicide-risk screening to guide treatment and monitor progress. Among youth with repeated depression assessments, median depression scores improved from 14 at baseline to 8 at follow-up. Suicide-risk severity decreased substantially during treatment, with moderate-to-high risk classifications declining from 37% to 11% and no-risk classifications increasing from 22% to 46%. Thirteen percent of youth ultimately required a higher level of psychiatric care. Among youth who completed the program, 95% were successfully connected to ongoing treatment, and 35% ultimately returned to primary-care-based medication management. CONCLUSIONS: The BCC illustrates how ambulatory crisis stabilization can serve as an intermediate component of the pediatric behavioral health crisis continuum by providing timely specialty intervention and facilitating structured transitions to ongoing care. Observed changes among youth with follow-up assessments suggested provisional improvement in clinical outcomes. As a resource for pediatric primary care, the BCC offers a valuable third pathway between routine outpatient management and emergency referral for youth whose needs exceed routine care but do not require hospitalization. Prospective comparative studies are needed to evaluate long-term outcomes, healthcare utilization, and system-level impact. |
Current problems in pediatric and adolescent health care | 2026 Nov 7 | PubMed |
| 11 | Corrigendum to "How do network structures of depressive symptoms differ between asian patients with bipolar depression and those with unipolar depression?" [Asian J. Psychiatry 122 (2026) 105062]. | Asian journal of psychiatry | 2026 Nov 7 | PubMed |
| 12 |
Mangiferin Buffers Depressive-Like Behaviors by Modulating Astrocytic DHHC2 in the Hippocampus.
View abstractSeveral lines of evidence indicate that mangiferin (MGF) ameliorates chronic stress-induced anxiety- and depressive-like behaviors, yet its precise role and underlying mechanisms remain poorly understood. Here, we show that MGF effectively alleviates anxiety- and depressive-like behaviors in mice exposed to chronic stress, accompanied by reduced synaptic loss and ameliorated hippocampal neurogenesis deficits. Notably, nuclear factor erythroid 2-related factor 2 (Nrf2) expression is preferentially altered in hippocampal astrocytes but not in neurons or microglia after chronic stress and MGF treatment, and knockdown of astrocytic Nrf2 abrogates the antidepressant effect of MGF. Further mechanistic studies showed that MGF reverses reactive astrogliosis by regulating astrocytic DHHC2-Nrf2 signaling, including Nrf2 palmitoylation and its nuclear translocation, thereby protecting Nrf2 from Keap1-mediated ubiquitination and proteasomal degradation and sustaining its transcriptional activity in reactive astrocytes. These findings demonstrate that MGF alleviates chronic stress-induced anxiety- and depressive-like behaviors by engaging the astrocytic DHHC2-Nrf2 signaling, suppressing reactive astrogliosis and reversing hippocampal synaptic and neurogenic deficits, which provides novel insights into the therapeutic potential of MGF for chronic stress-related mood disorders. |
Pharmacological research | 2026 Nov 7 | PubMed |
| 13 |
Temporal and Spatial Dynamics and Mechanisms of Brain-Gut Axis Injury Induced by Confinement-Like Physical Restraint Stress in Mice.
View abstractBACKGROUND: Long-term SIS exposure across aerospace, deep-sea, underground, and quarantine settings increases depression and gut-brain axis dysfunction risk, but long-term nonlinear injury dynamics remain poorly understood. METHODS: We analyzed GBD 2023 depression burden data in adults aged 15-49, then established a 0-35 day (d) chronic restraint stress mouse model that isolates the core physical confinement and activity-restriction component of SIS. Integrating behavior, histology, biochemistry, 16S sequencing, metabolomics, and formal nonlinear changepoint analysis, we validated picolinic acid (PLA) effects via in vivo intervention, in silico docking, and fecal microbiota transplantation (FMT). RESULTS: Population data showed that the global depression burden during the COVID-19 period followed a rapid rise-partial recovery-persistent disability pattern, providing a temporal reference for the experimental model. In mice, confinement-like restraint stress induced triphasic nonlinear gut-brain injury with changepoints at ~7 and ~21 days: early HPA/inflammatory activation, mid-phase gut barrier disruption and anxiety-like behavior, and late hippocampal damage with despair-like behavior. Microbiota remodeling and tryptophan metabolic shift formed the core signaling cascade, with PLA identified as the key gut-brain metabolite. Exogenous PLA dose-dependently improved depressive phenotypes, repaired barriers, and suppressed HPA hyperactivity and inflammation. FMT provided suggestive evidence that gut microbiota contribute to PLA's protective effects. CONCLUSION: Chronic confinement-like restraint stress induces triphasic nonlinear gut-brain axis injury rather than linear damage. PLA is a promising candidate target for mental health protection in isolated, confined, extreme environment populations and stress-related depression intervention. |
Pharmacological research | 2026 Nov 7 | PubMed |
| 14 |
Optimizing cognitive and behavioural recovery after stroke: clinical integration of dietary supplements with a focus on ω-3 fatty acids.
View abstractStroke remains a leading cause of long-term disability worldwide, with many survivors experiencing persistent cognitive and behavioural impairments despite advancements in acute management. Post-stroke neurorecovery is often incomplete, contributing to dementia, depression, and reduced quality of life, particularly in low- and middle-income settings where access to advanced rehabilitation and therapeutics is limited. This highlights an urgent need for accessible, adjunctive strategies that can enhance functional recovery. Emerging preclinical evidence indicates that dietary supplements can modulate key biological processes underlying neurorecovery, including neuroplasticity, neuroinflammation, oxidative stress, mitochondrial function, and synaptic remodeling. In this narrative review, we examine the role of major classes of nutraceuticals such as omega-3 fatty acids, vitamins, minerals, polyphenols, and amino acids in supporting cognitive and behavioural recovery after stroke with particular emphasis on omega-3 fatty acids, given their central role in neuronal membrane integrity, lipid-mediated signaling, and resolution of inflammation. We integrate mechanistic insights with preclinical and clinical data explicitly highlighting that theoretical models and basic research demonstrate significant promise, while current clinical evidence remains heterogeneous and frequently inconclusive. We discuss how dietary supplementation might be strategically incorporated alongside conventional rehabilitation paradigms including physiotherapycognitive training, and pharmacotherapy. We further highlight emerging concepts such as the gut-brain axis, precision nutrition, and biomarker-guided interventions, which are shaping the future of personalized neurorehabilitation. Ultimately, while dietary supplements offer a promising, cost-effective and accessible adjunctive approach. their current clinical utility is constrained by mixed translational efficacy. Overcoming these limitations will require rigorous patient selection, optimized timing, and shift towards evidence-based personalized, multimodal strategies. This will be essential to fully harness their therapeutic potential in improving cognitive and behavioural outcomes in stroke recovery. |
Neurochemistry international | 2026 Nov 7 | PubMed |
| 15 |
Long term maintenance of patient defined goals following pulmonary rehabilitation in COPD: An observational study.
View abstractINTRODUCTION: Pulmonary rehabilitation (PR) is a key treatment for patients with COPD. The main challenge in PR is maintaining benefits over the long term. The main objective of this observational study was to evaluate the proportion of patients who maintained at least half of their personal goals, as determined during the PR programme (PRP), at one year. METHODS: Patients with COPD admitted to a PRP were prospectively included in this observational study. At the end of the PRP, patients were assessed using standard tools (exercise capacity, dyspnea, quality of life…) and developed a written plan for goal maintenance. Patients were then assessed at 6 and 12 months. The primary endpoint was maintenance of the goal(s) determined by the patient at 12 months. The secondary endpoints were the maintenance of the goal(s) at 6 months and the maintained benefits of the PRP at 12 months. RESULTS: 221 patients were included and 214 analysed. Fifty one percent of the patients maintained at least half of their goals at 12 months and sixty four percent of the patients at 6 months. At 12 months, anxiety was not significantly altered, and the increases in dyspnea and depression, as well as the decrease in exercise capacity and quality of life, were significant but not clinically relevant (except quality of life). CONCLUSION: after a PRP including a written plan for maintaining goals, half of the patients maintained at least half of their goals at 12 months, without experiencing a clinically relevant decline in PR benefits. |
Respiratory medicine | 2026 Nov 7 | PubMed |
| 16 |
The Separation-Distress Network as a Transdiagnostic Mechanism Linking Relational Adversity, Social Pain, and Psychopathology.
View abstractRelational trauma is a major contributor to the development of mental health disorders. This association likely reflects the social nature of humans and other mammals, whose survival depends on maintaining stable social bonds. When these bonds are threatened or disrupted, individuals experience social pain, a distress response mediated by the mammalian separation-distress network. During early development, this network is sensitive to maintaining proximity with caregivers, as independent survival is not yet possible. Converging evidence from ethology, psychodynamic and attachment theory, and social and affective neuroscience supports the function of this network. Because mammalian brains are inherently tuned to form social bonds, adverse relational experiences can disrupt socioemotional development and increase vulnerability to psychopathology. Neural substrates of separation distress include the anterior cingulate cortex, ventral septum, bed nucleus of the stria terminalis, dorsal preoptic area, dorsomedial thalamus, and periaqueductal gray, with endogenous opioids and glucocorticoids serving as key neurochemical modulators in the separation-distress response. Separation distress and adverse relational experiences also alter physiological systems implicated in psychopathology, including the HPA axis, autonomic nervous system activity, inflammation, and brain structure and connectivity. This paper argues that relational trauma and social pain are mediated by an evolutionarily conserved subcortical separation-distress network shared across predominantly mammalian species. Dysregulation of this network may represent one common mechanism underlying depression, social anxiety, suicidality, substance use disorders, borderline personality disorder, and other psychiatric conditions. Understanding the processes linking adverse relational experiences, separation-distress activation, and social pain may provide insights into the etiology and treatment of diverse disorders. |
Neuroscience and biobehavioral reviews | 2026 Nov 7 | PubMed |
| 17 |
Examining the Relationship Between Regional Vulnerability and Psychotic-Like Experiences in Adolescents: The Potential Mediating Role of Cognition.
View abstractBACKGROUND: Psychotic-like experiences (PLEs) are subclinical hallucinations or unusual thought content that, when distressing or persistent, signal heightened risk for psychosis spectrum disorders and cognitive impairments. METHODS: We used data from the Adolescent Brain Cognitive Development (ABCD) study (N = ∼11,800) to examine if structural brain deviations toward neuropsychiatric disorders, quantified using disorder-specific Regional Vulnerability Indices (RVIs), were associated with distressing PLEs at age 13-14, and whether cognition mediated these relationships. Cortical and subcortical RVIs were calculated for schizophrenia, bipolar disorder, major depressive disorder, Alzheimer's disease, Parkinson's disease, metabolic disorder, and 22q11.2 deletion syndrome. RESULTS: Linear mixed-effects models revealed that higher cortical RVIs for schizophrenia, Alzheimer's disease, bipolar disorder, metabolic disorder, and Parkinson's disease-and all subcortical RVIs-were significantly associated with greater distressing PLE severity. Both cortical and subcortical RVIs were negatively associated with fluid and crystallized cognition, with subcortical RVIs showing the largest effects. Mediation analyses indicated that crystallized cognition, and to a lesser extent fluid cognition, mediated many RVI-distressing PLE relationships. DISCUSSION: These findings suggest that neuroanatomical differences confer risk for psychotic-like experiences partly through their impact on cognitive development. The results highlight RVIs as sensitive markers of distributed brain vulnerability in youth and suggest that cognitive function, particularly crystallized ability, is a potential pathway linking brain structural alterations to emerging psychotic symptoms. |
Biological psychiatry. Cognitive neuroscience and neuroimaging | 2026 Nov 7 | PubMed |
| 18 |
ACEs and CKL diseases in middle and old age: Multistate model and MR analysis of a national cohort.
View abstractBACKGROUND: Adverse childhood experiences (ACEs) are associated with chronic diseases, but evidence regarding their impact on cardiovascular, kidney, and liver (CKL) diseases and multimorbidity remains limited. This study examines the association between ACEs and the onset of CKL diseases, and explores the potential mediating role of depressive symptoms. METHODS: The study included 7184 middle-aged and older adults aged ≥45 years without CKL disease at baseline from the China Health and Retirement Longitudinal Study (CHARLS, 2011-2018). Cox models were used to assess the association between ACEs and new-onset disease; multistate models were employed to analyse the risk of disease transition; mediation analysis was conducted to examine the mediating role of depressive symptoms. Two-sample Mendelian randomization was further applied as an independent triangulation analysis of the association between genetic liability to depression and selected outcomes. RESULTS: During a median follow-up of 84 months, there were 1428, 547, 379 and 300 new cases of CVD, CKD, CLD and CKL multimorbidity, respectively. The risk of CVD, CKD, CLD and CKL multimorbidity was increased by 30% [95% confidence interval (CI): 1.15, 1.45], 37% (95% CI: 1.13, 1.66), 35% (95% CI: 1.07, 1.70) and 46% (95% CI: 1.12, 1.89), respectively, with a graded association observed across ACE categories (all P-trend <0.05). ACEs were significantly associated with the initial transition from health to CKL disease. Depressive symptoms acted as a potential mediator, and Mendelian randomization provided genetic evidence on the association between depression and selected cardiovascular outcomes. CONCLUSION: ACEs were associated with higher risks of CVD, CKD, CLD and CKL multimorbidity in middle-aged and older adults, with depressive symptoms as a potential mediator. ACE history and depressive symptoms may help identify high-risk individuals, supporting further exploration of integrated management strategies for chronic diseases. |
Experimental gerontology | 2026 Nov 7 | PubMed |
| 19 |
Studying the pharmacological interaction of temozolomide chemotherapy with different antidepressant treatments in a rat glioblastoma model.
View abstractThe present study evaluated the pharmacological interaction of temozolomide (TMZ) chemotherapy with 3 potential antidepressant treatments (cannabidiol, CBD; fluoxetine, FLX; metformin, MET) in a rat glioblastoma model with the objective of finding drug combinations to better treat the depressive symptoms observed in glioblastoma patients. Methods Adult male Fisher 344 rats were inoculated with syngeneic RG2 cells into the right striatum. Then, rats received the antitumoral drug (TMZ, 25 mg/kg) vs. its vehicle (C-group), and 3 h later, treated with CBD (30 mg/kg), FLX (10 mg/kg), MET (100 mg/kg) or vehicle (Veh-group) for 5 days. The forced-swim test was used to score antidepressant-like responses. Markers of treatment response were evaluated in brain samples (hippocampal neurogenesis) of the non-tumor-infiltrated hemisphere and in blood plasma (corticosterone and immune system cells). Results The main results showed that TMZ alone and/or in combination with different types of potential antidepressants (CBD, FLX, MET) did not alter behavioral performance assessed in the forced-swim test. The absence of behavioral effects, however, is not attributed to a lack of pharmacological effects of the specific drugs. TMZ treatment decreased body weight gain, reduced the number of hippocampal neural progenitors and diminished immune plasma markers, while CBD and FLX decreased plasma corticosterone. Conclusion In conjunction, our results did not support the hypothesis of a beneficial use of antidepressants as a combinational therapy with TMZ to attenuate the most associated comorbidity of glioblastoma, depression, at least in male rats with this specific model of experimentally induced glioblastoma. |
Neuroscience | 2026 Nov 7 | PubMed |
| 20 |
Stroboscopic light stimulation in adults reporting depressive symptoms: Safety, tolerability, feasibility, and active-comparator development in a staged early-phase study.
View abstractStroboscopic light stimulation (SLS) is a candidate non-pharmacological intervention that induces transient visual and affective experiences, with potential application in depression. Before efficacy testing, clinical development requires safety, tolerability, and feasibility data. We report a staged, single-site programme in adults reporting depressive symptoms. Study 1 tested 11 SLS parameter sets for safety and tolerability. Study 2 assessed whether an active comparator reduced subjective visual effects while preserving session context. Study 3 randomised 84 participants to four weekly supervised 31-minute sessions of strobe-emphasis or wash-emphasis SLS. In Study 1, 31 participants were analysed; no severe adverse reactions occurred, mean discomfort was low (0.49/10), and the highest session-level upper 80% confidence limit was 1.13/10, well below the prespecified threshold. Study 2 supported within-participant experiential separation between the two SLS configurations in healthy adults. In Study 3, endpoint data were available for 70/84 randomised participants (83.3%): 39/42 assigned to strobe-emphasis and 31/42 assigned to wash-emphasis. Discomfort remained low, with no serious SLS-attributable adverse events. Both configurations produced visual phenomenology in the Study 3 target sample, and the phenomenological separation observed during Study 2 was not reproduced between groups in Study 3. The comparison estimates differences between two active SLS configurations, rather than SLS versus no stimulation. Exploratory depressive-symptom estimates were imprecise, limited by differential endpoint availability, and should inform endpoint selection and subsequent trial design rather than efficacy. Overall, the programme supports further controlled evaluation of supervised SLS while identifying experiential separation, retention, masking, and endpoint selection as priorities for the next trial. |
Journal of affective disorders | 2026 Nov 7 | PubMed |
| 21 |
Dynamic, interactive change in autobiographical memory, cognition, and depression in young adults: A longitudinal cohort study.
View abstractDepression is characterised by biases in memory and everyday cognition, however, there is limited understanding of how the interplay between different cognitive processes predicts the development of depressive symptoms. Here, we evaluated the dynamic interactions between autobiographical memory retrieval, problem solving, cognitive reappraisal, social support, and self-beliefs over a twelve-month period, to determine how direct and indirect relationships between core cognitive processes predict change in depression symptoms for young adults. Our longitudinal cohort study of 793 community-based young adults used latent change score models to show that negative and positive self-beliefs predicted change in depression symptoms, and depression symptoms predicted change in negative self-beliefs. In linear regression analyses, autobiographical memory retrieval predicted problem solving and reappraisal skills 6-months later, although no indirect relationships were observed between memory and cognition in predicting later depression symptoms. Results emphasise the need for further theoretical consideration and the use of advanced methodologies to account for the dynamic interplay between memory and cognition in predicting depression in young adults. Understanding these changes is not only of theoretical importance, but may inform the development of preventative interventions. |
Journal of affective disorders | 2026 Nov 7 | PubMed |
| 22 |
Working memory neural correlates after ketamine in treatment-resistant depression: a randomized placebo-controlled functional magnetic resonance imaging study.
View abstractKetamine exerts rapid antidepressant effects in treatment-resistant depression (TRD), but its impact on working memory and neural circuitry remains unclear. This secondary analysis investigated behavioral and neural changes during a working memory task post-ketamine infusion in TRD participants versus healthy volunteers (HVs). Data were previously collected from a randomized, double-blind, placebo-controlled, crossover trial of 22 unmedicated TRD participants (14F/8 M) and 19 matched HVs (12F/7 M). Participants received ketamine (0.5mg/kg) and placebo two weeks apart. 3T fMRI was acquired during an N-back task at baseline and two days post-ketamine. Accuracy, reaction time, and differential neural activation during 3-back versus 1-back contrasts were analyzed. Ketamine significantly reduced Montgomery-Asberg Depression Rating Scale scores compared to placebo (p < 0.01). N-back task performance did not significantly differ between drug conditions. In region of interest (ROI) analyses, TRD participants showed reduced activation in the superior temporal gyrus versus HVs (p < 0.01) after both infusions, and both groups demonstrated decreased parieto-occipital junction activation post-ketamine versus post-placebo (p = 0.01). Baseline dorsolateral prefrontal cortex activity significantly predicted post-infusion activity (p < 0.01). Ketamine's antidepressant effects occurred without significant changes in working memory performance, though region-specific task-related brain changes were observed. Interpretation is limited by modest sample size and the exploratory nature of the ROI analyses. CLINICAL TRIAL REGISTRATION: www.clinicaltrials.gov, NCT00088699. |
Psychiatry research. Neuroimaging | 2026 Nov 3 | PubMed |
| 23 |
Early self-regulation in context: Multidimensional organization of neonatal non-nutritive sucking and its association with subclinical maternal depressive traits.
View abstractFrom the very first days of life, infants' affective regulation unfolds within a dyadic co-regulatory system shaped by caregiver responsivity. In contexts of reduced maternal availability, such as maternal depressive states, infants may be required to compensate for diminished interpersonal regulation by increasingly relying on their internal resources. Neonatal non-nutritive sucking (NNS) represents one of the earliest spontaneously available regulatory behaviors, contributing to physiological and behavioral homeostasis from birth. However, it remains unclear whether its spontaneous organization is associated with early relational vulnerability indexed by maternal depressive symptoms. The present study aimed to characterize the spontaneous organization of NNS in a sample of newborns (N = 42) and to examine whether individual differences in NNS are associated with maternal postnatal depressive subclinical traits measured using the Edinburgh Postnatal Depression Scale (EPDS). Results from an exploratory principal component analysis indicated that neonatal sucking behavior was organized along two functional dimensions, reflecting overall sucking effort and behavioral activation, and the temporal organization of sucking bursts. Importantly, higher maternal depressive traits, though subclinical, were selectively associated with increased sucking effort, with infants of mothers reporting higher depressive traits showing more frequent and intense sucking, while no differences emerged for the organizational dimension. Overall, these findings suggest that individual differences in maternal depressive traits within the subclinical range may be associated with neonatal NNS effort, a precocious compensatory mobilization of regulatory resources, potentially serving both to support autonomous regulation and to elicit maternal engagement. |
Journal of experimental child psychology | 2026 Nov 7 | PubMed |
| 24 | Reconceptualizing psychiatric functional near-infrared spectroscopy: From surface hemodynamics to machine learning-derived deep network inference. | Asian journal of psychiatry | 2026 Nov 5 | PubMed |
| 25 |
Autistic matrescence as dynamic person-environment fit: a theoretical model of regulatory resources and support usability.
View abstractBACKGROUND: Matrescence is a developmental transition involving bodily, psychological, relational, and social change. Research on autistic pregnancy and early parenthood documents sensory overload, communication barriers, disrupted routines, professional scrutiny, and limited recovery alongside attachment, commitment, competence, and self-knowledge. Such divergence requires a model treating neither autism nor parenthood as sufficient explanations of psychological outcomes. APPROACH: This theoretical paper reuses the 25-publication corpus of a published mapping review on autistic pregnancy, childbirth, postpartum experience, infant feeding, and early parenting. It develops a distinct theoretical synthesis by integrating that corpus with theories of stress, resource loss, functioning, and person-environment-occupation fit; it does not report a new review or formal study-quality appraisal. MODEL: The paper proposes that proximal psychological outcomes are shaped by dynamic person-environment fit among transition demands, state-dependent regulatory resources, and environmental demands and affordances. Its specific extension is the distinction between support availability and usability. Support usability is modelled as a staged conversion process through which available support must be accessed, processed, trusted, and implemented to become psychologically effective. The model specifies boundary conditions under which minority stress, trauma, psychopathology, acute clinical complications, or structural violence should be treated as primary explanations. IMPLICATIONS: Five propositions address within-person variation, sensory and communication moderation, recovery mediation, support usability, and reciprocal developmental feedback. Candidate measures are mapped onto instruments, including the Glasgow Sensory Questionnaire, state anxiety, perceived stress, the Edinburgh Postnatal Depression Scale, parenting confidence, parenting styles, and preliminary autistic-burnout measures. Generalization beyond autistic matrescence is presented as a transfer hypothesis rather than an established contribution. |
Acta psychologica | 2026 Nov 7 | PubMed |

